Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cathepsin C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | cathepsin C | 141 aa | 152 aa | 22.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | glucosylceramidase, putative | 0.0284 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0284 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0196 | 0.6379 | 0.3787 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0284 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0284 | 1 | 1 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0186 | 0.5964 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.023 | 0.7784 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.023 | 0.7784 | 1 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0073 | 0.1263 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0284 | 1 | 1 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0284 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.023 | 0.7784 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.023 | 0.7784 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0284 | 1 | 1 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0073 | 0.1263 | 0.5 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0073 | 0.1263 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.023 | 0.7784 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0073 | 0.1263 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.023 | 0.7784 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0196 | 0.6379 | 0.3787 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.023 | 0.7784 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0073 | 0.1263 | 0.5 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0073 | 0.1263 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.5964 | 0.3075 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0073 | 0.1263 | 0.5 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.023 | 0.7784 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.